U.S. In Situ Hybridization Market Size & Outlook
U.S. in situ hybridization market, 2018-2030 (US$M)
Related Markets
U.S. in situ hybridization market highlights
- The U.S. in situ hybridization market generated a revenue of USD 643.6 million in 2023 and is expected to reach USD 966.7 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6% from 2024 to 2030.
- In terms of segment, fish was the largest revenue generating technology in 2023.
- CISH is the most lucrative technology segment registering the fastest growth during the forecast period.
In situ hybridization market data book summary
| Market revenue in 2023 | USD 643.6 million |
| Market revenue in 2030 | USD 966.7 million |
| Growth rate | 6% (CAGR from 2023 to 2030) |
| Largest segment | Fish |
| Fastest growing segment | CISH |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | FISH, CISH |
| Key market players worldwide | Thermo Fisher Scientific Inc, Abbott Laboratories, Agilent Technologies Inc, Merck KGaA, Bio-Rad Laboratories Inc, Bio View Ltd, Revvity Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 40.3% of the global in situ hybridization market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. in situ hybridization market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 100.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In Situ Hybridization Market Scope
In Situ Hybridization Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. in situ hybridization market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in situ hybridization market will help companies and investors design strategic landscapes.
Fish was the largest segment with a revenue share of 53.57% in 2023. Horizon Databook has segmented the U.S. in situ hybridization market based on fish, cish covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. held a substantial share of the North America in situ hybridization market owing to high incidence of genetic disorders, such as abnormalities, developmental disabilities, and metabolic syndrome. FISH is estimated to provide 98% accuracy in detecting chromosomal aberrations leading to such disorders.
According to CDC, around 3% to 4% of infants in the U.S. have genetic abnormalities. In addition, approximately 10% of adults and 30% of children in the U.S. are hospitalized due to genetic disorders. ISH is also used in the diagnosis of cancers as a consequence of chromosomal modifications.
Reasons to subscribe to U.S. in situ hybridization market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. in situ hybridization market databook
-
Our clientele includes a mix of in situ hybridization market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. in situ hybridization market , including forecasts for subscribers. This country databook contains high-level insights into U.S. in situ hybridization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. in situ hybridization market size, by technology, 2018-2030 (US$M)
U.S. In Situ Hybridization Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
